Pre-clinical activity of a novel immunotherapy combination of CAVATAK (Coxsackievirus A21), anti-PD1 blockade and an IDO inhibitor in melanoma
- Resource Type
- Journal
- Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER ; NOV 7 2017, 5 2p. Supplement: 2- Subject
- Language
- English
- ISSN
- 20511426